ENG and neuroblastoma: The use of TRC105 (an anti-CD105 antibody) in primary NB cell lines or combined with Dinutuximab and activated NK cells in NB mice models, restored ADCC-mediated cytotoxicity, and effectively eradicated the tumors [191, 192].